Market capitalisation, EUR | 115,387.48 m |
EPS, EUR | - |
P/B ratio | 1.50 |
P/E ratio | 21.07 |
Dividend yield | 2.80% |
Revenue, EUR | 43,070.61 m |
Net income, EUR | 5,400.08 m |
Profit margin | 12.54% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.61% | Equity United States Dividend | 165 | 0.70% | 18 | +7.39% | A2PZMV | IE00BKVKW020 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.38% | Equity United States Health Care Biotech | 222 | 0.35% | 32 | +2.62% | A2JDYM | IE00BDZVHG35 |
iShares Nasdaq US Biotechnology UCITS ETF | 1.38% | Equity United States Health Care Biotech | 222 | 0.35% | 416 | +3.15% | A2DWAW | IE00BYXG2H39 |
Invesco Nasdaq Next Generation 100 UCITS ETF Acc | 0.91% | Equity United States Technology | 104 | 0.25% | 41 | +17.45% | A2QPVX | IE00BMD8KP97 |